Charl Coleman

623 total citations
11 papers, 256 citations indexed

About

Charl Coleman is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Charl Coleman has authored 11 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Charl Coleman's work include Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Charl Coleman is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Charl Coleman collaborates with scholars based in United States, Netherlands and South Africa. Charl Coleman's co-authors include Marion Vermeulen, Ravi Shankar Reddy, Nico Lelie, Harry van Drimmelen, Michael P. Busch, Caroline Dickens, Anna Kramvis, Robert Crookes, Wendy Sykes and Eduard Grebe and has published in prestigious journals such as Transfusion, Vox Sanguinis and Retrovirology.

In The Last Decade

Charl Coleman

11 papers receiving 238 citations

Peers

Charl Coleman

EPIDE

HEPAT

MTI

VIROL

James Brandful Ghana

Hideo Naito Japan

M.H. Elghouzzi France

Jinfeng Zeng China

S Tanprasert Thailand

Hisao Yugi Japan

C. T. Fang United States

M. Damen Netherlands

Ashish C. Shrestha Australia

Marijke Weber‐Schehl Germany

James Brandful Ghana

Charl Coleman

106 ×0.6

EPIDE

69 ×0.4

HEPAT

31 ×0.4

MTI

75 ×1.4

77 ×2.5

VIROL

Citations per year, relative to Charl Coleman Charl Coleman (= 1×) peers James Brandful

Countries citing papers authored by Charl Coleman

Since Specialization

Citations

This map shows the geographic impact of Charl Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charl Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charl Coleman more than expected).

Fields of papers citing papers by Charl Coleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charl Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charl Coleman. The network helps show where Charl Coleman may publish in the future.

Co-authorship network of co-authors of Charl Coleman

This figure shows the co-authorship network connecting the top 25 collaborators of Charl Coleman. A scholar is included among the top collaborators of Charl Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charl Coleman. Charl Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Vermeulen, Marion, Laurette Mhlanga, Wendy Sykes, et al.. (2023). The evolution and interpretation of seroprevalence of SARS‐CoV‐2 antibodies among South African blood donors from the Beta to Omicron variant‐driven waves. Vox Sanguinis. 119(3). 242–251. 1 indexed citations

Lelie, Nico, Marion Vermeulen, Harry van Drimmelen, et al.. (2020). Direct comparison of three residual risk models for hepatitis B virus window period infections using updated input parameters. Vox Sanguinis. 115(3). 133–145. 10 indexed citations

Coleman, Charl, et al.. (2020). Comparison of two nucleic acid amplification technology systems for detection of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus. Transfusion. 60(12). 2929–2937. 5 indexed citations

Vermeulen, Marion, Wendy Sykes, Charl Coleman, et al.. (2019). The prevalence of human T‐lymphotropic virus type 1 & 2 (HTLV‐1/2) in South African blood donors. Vox Sanguinis. 114(5). 451–458. 18 indexed citations

Vermeulen, Marion, Harry van Drimmelen, Charl Coleman, et al.. (2019). Reassessment of hepatitis B virus window periods for two transcription‐mediated amplification assays using screening data of South African blood donors. Transfusion. 59(9). 2922–2930. 11 indexed citations

Vermeulen, Marion, Nico Lelie, Charl Coleman, et al.. (2018). Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes. Transfusion. 59(1). 267–276. 41 indexed citations

Sykes, Wendy, Charl Coleman, G Beck, et al.. (2015). Cost-effectiveness analysis of introducing HTLV-1 testing in South Africa. Retrovirology. 12(S1). 1 indexed citations

Vermeulen, Marion, et al.. (2014). A mathematical approach to estimate the efficacy of individual‐donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections. Transfusion. 54(10). 2496–2504. 18 indexed citations

Vermeulen, Marion, et al.. (2013). Sensitivity of individual‐donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections. Transfusion. 53(10pt2). 2459–2466. 49 indexed citations

10.

Vermeulen, Marion, Charl Coleman, Ravi Shankar Reddy, et al.. (2013). Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk. Transfusion. 53(10pt2). 2384–2398. 32 indexed citations

11.

Vermeulen, Marion, Caroline Dickens, Nico Lelie, et al.. (2011). Hepatitis B virus transmission by blood transfusion during 4 years of individual‐donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion. 52(4). 880–892. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact